Clinical Trials Logo

Clinical Trial Summary

Despite a large and growing body of knowledge concerning the diagnosis of temporal arteritis, this potentially crippling disease still requires pathological diagnosis in practically every case. It seems likely that a correctly estimated clinical probability could help in evaluating imaging results in a way that might safely obviate temporal biopsy in a large segment of suspect cases.

With this aim in view, we intend to identify useful clinical items and integrate them in an appropriate diagnostic pathway.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only


Related Conditions & MeSH terms


NCT number NCT01130857
Study type Observational
Source Tel-Aviv Sourasky Medical Center
Contact Israel SA Heller, MD
Phone +97236973375/6
Email heller@tasmc.health.gov.il
Status Not yet recruiting
Phase N/A
Start date July 2010
Completion date July 2012

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06244069 - Clonal Hematopoiesis in Giant Cell Arteritis
Completed NCT02476292 - Impact of Vasculitis on Employment and Income N/A
Withdrawn NCT02584517 - Aetiology of TemporaL Arteritis Study
Completed NCT03410290 - Journey of Patients With Vasculitis From First Symptom to Diagnosis
Terminated NCT02955147 - Ustekinumab for the Treatment of Giant Cell Arteritis Phase 1/Phase 2
Recruiting NCT00361192 - Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis Phase 0
Completed NCT00315497 - Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Completed NCT00188448 - MRI Superficial Temporal Artery Phase 1
Recruiting NCT03840928 - PatientSpot Formerly Known as ArthritisPower